COVID-19 Records

Tony's Diary Package — page 1025

of 1141 pages

← p.1024 p.1026 → · this page in the original PDF · package

loyed aster inical atment Guidelines to speed innovation leading March 16: The Phase 1 clinical trial started for the investigational vaccine, known as mRNA-1273, codeveloped by NIH and Moderna. Press release Blurb: NIH/Moderna COVID vaccine Phase 1 clinical trial started Image: 3.16.20 Phase 1 Moderna April 17: NIH launched the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) initiative, a public-private partnership focused on developing treatments and vaccines for COVID-19. ACTIV streamlined the process for adding new agents into trials and rapidly deployed existing NIH networks of more than 620 trial sites across the U.S. and internationally. The initiative evaluated over 800 therapeutic agents and prioritized 33 for inclusion in ACTIV master protocols. Six of these agents have shown compelling evidence of benefit in randomized clinical trials. Press release Blurb: NIH launched ACTIV, a public-private partnership to develop treatments and vaccines Image: 4.17.20 ACTIV April 21: After convening a panel of academic and government experts to critically review and synthesize available data from clinical trials and other study reports, the first NIH COVID-19 Treatment Guidelines were published to provide clinicians with guidance on how to care for patients with COVID-19. The panel has issued more than 50 updated editions since April 2020 and the guidelines have been visited more than 30 million times. Press release Blurb: NIH published the COVID-19 Treatment Guidelines April 29: NIH launched the Rapid Acceleration of Diagnostics (RADx) initiative to speed innovation leading to reliable diagnostic testing. Press release Blurb: NIH launched RADx initiative to speed innovation in diagnostic testing Image: 4.29.20 RADx May 22: Preliminary peer-reviewed data from the ACTT-1 trial indicated that the antiviral drug remdesivir is safe and improved clinical outcomes for hospitalized adults with COVID-19. Press release Blurb: Antiviral drug remdesivir found safe and effective. Image: https://www.shutterstock.com/image-photo/medication-prepared-people-affected-bycovid19-1731814354

This is our OCR of the page, with running headers and footers removed. The Committee's PDF is authoritative; quote from it. Machine-readable, including the uncleaned text: /api/page/fauci_diary/1025

Records on this page

RecordDateTypePages
August 16, 2022 2022-08-16 diary entry 1023–1031